Ventas, Inc. $VTR Position Reduced by Groupama Asset Managment

Groupama Asset Managment reduced its stake in shares of Ventas, Inc. (NYSE:VTR) by 97.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 12,794 shares of the real estate investment trust’s stock after selling 551,326 shares during the quarter. Groupama Asset Managment’s holdings in Ventas were worth $990,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Bridgewater Advisors Inc. raised its stake in shares of Ventas by 2.0% in the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after purchasing an additional 133 shares in the last quarter. IHT Wealth Management LLC grew its stake in Ventas by 3.2% in the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after purchasing an additional 137 shares in the last quarter. True Wealth Design LLC increased its holdings in Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares during the last quarter. Cigna Investments Inc. New increased its holdings in Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 142 shares during the last quarter. Finally, Parallel Advisors LLC raised its stake in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after buying an additional 175 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Trading Up 0.0%

NYSE:VTR opened at $81.61 on Friday. The stock has a market cap of $39.68 billion, a price-to-earnings ratio of 148.38, a PEG ratio of 1.75 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $91.06. The business has a fifty day moving average of $85.07 and a 200-day moving average of $82.58.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.5%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on VTR. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research report on Monday, May 4th. JPMorgan Chase & Co. lifted their price objective on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Jefferies Financial Group boosted their target price on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. UBS Group raised their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Finally, Evercore reaffirmed an “outperform” rating and issued a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $96.00.

Insider Transactions at Ventas

In related news, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.